Quidelortho Corp
General ticker "QDEL" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.8B
Quidelortho Corp does not follow the US Stock Market performance with the rate: -27.4%.
Estimated limits based on current volatility of 2.0%: low 43.84$, high 45.65$
Factors to consider:
- US accounted for 61.0% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [46.39$, 80.74$]
- 2024-12-30 to 2025-12-30 estimated range: [46.45$, 80.48$]
Financial Metrics affecting the QDEL estimates:
- Positive: Non-GAAP EPS, $ of 4.13 > 2.29
- Positive: 1.03 < Operating profit margin, % of 4.64
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of -0.12
- Positive: -3.48 < Investing cash flow per share, $ of -2.81
Short-term QDEL quotes
Long-term QDEL plot with estimates
Financial data
| YTD | 2021-12-31 | 2023-01-01 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,698.55MM | $3,266.00MM | $2,997.80MM |
| Operating Expenses | $792.49MM | $2,422.30MM | $2,858.70MM |
| Operating Income | $906.07MM | $843.70MM | $139.10MM |
| Non-Operating Income | $-5.71MM | $-107.80MM | $-168.20MM |
| Interest Expense | $5.71MM | $75.70MM | $178.90MM |
| R&D Expense | $95.70MM | $190.50MM | $246.80MM |
| Income(Loss) | $900.36MM | $735.90MM | $-29.10MM |
| Taxes | $196.16MM | $187.20MM | $-19.00MM |
| Profit(Loss) | $704.20MM | $548.70MM | $-10.10MM |
| Stockholders Equity | $1,929.36MM | $4,934.60MM | $5,005.90MM |
| Inventory | $198.76MM | $524.10MM | $577.80MM |
| Assets | $2,430.37MM | $8,855.80MM | $8,563.10MM |
| Operating Cash Flow | $805.87MM | $885.30MM | $280.20MM |
| Capital expenditure | $292.72MM | $140.90MM | $209.30MM |
| Investing Cash Flow | $-319.53MM | $-1,644.20MM | $-187.60MM |
| Financing Cash Flow | $-173.18MM | $252.00MM | $-265.80MM |
| Earnings Per Share* | $16.74 | $9.66 | $-0.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.